SE8604114L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8604114L
SE8604114L SE8604114A SE8604114A SE8604114L SE 8604114 L SE8604114 L SE 8604114L SE 8604114 A SE8604114 A SE 8604114A SE 8604114 A SE8604114 A SE 8604114A SE 8604114 L SE8604114 L SE 8604114L
Authority
SE
Sweden
Prior art keywords
cefuroxime axetil
film coat
pharmaceutical composition
film
tablet core
Prior art date
Application number
SE8604114A
Other languages
English (en)
Swedish (sv)
Other versions
SE8604114D0 (sv
Inventor
J Anwar
D S Deutsch
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10585921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8604114(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8604114D0 publication Critical patent/SE8604114D0/xx
Publication of SE8604114L publication Critical patent/SE8604114L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)
SE8604114A 1985-09-30 1986-09-29 Farmaceutisk komposition SE8604114L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858524001A GB8524001D0 (en) 1985-09-30 1985-09-30 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
SE8604114D0 SE8604114D0 (sv) 1986-09-29
SE8604114L true SE8604114L (sv) 1987-03-31

Family

ID=10585921

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604114A SE8604114L (sv) 1985-09-30 1986-09-29 Farmaceutisk komposition

Country Status (29)

Country Link
US (1) US4897270A ( )
EP (1) EP0223365B1 ( )
JP (1) JP2661662B2 ( )
KR (1) KR940000233B1 ( )
AT (1) AT393081B ( )
AU (1) AU594082B2 ( )
BE (1) BE905518A ( )
CA (1) CA1282331C ( )
CH (1) CH672736A5 ( )
CY (1) CY1563A ( )
DE (2) DE3677710D1 ( )
DK (1) DK175349B1 ( )
ES (1) ES2002382A6 ( )
FR (1) FR2591597B1 ( )
GB (2) GB8524001D0 ( )
GR (1) GR862464B ( )
HK (1) HK84990A ( )
IE (1) IE59089B1 ( )
IL (1) IL80165A ( )
IT (1) IT1196644B ( )
LU (1) LU86613A1 ( )
NL (1) NL8602466A ( )
NO (1) NO173636C ( )
NZ (1) NZ217720A ( )
PH (1) PH25702A ( )
PT (1) PT83459B ( )
SA (1) SA91120189B1 ( )
SE (1) SE8604114L ( )
ZA (1) ZA867318B ( )

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
AT393955B (de) * 1990-03-30 1992-01-10 Martin Dr Leixnering Einrichtung zur nachbehandlung frischer beugesehnenverletzungen
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
GB2256587A (en) * 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B ( ) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
JP2002505290A (ja) * 1998-03-03 2002-02-19 ダエウン ファーマシューティカル カンパニー リミテッド 水分吸収に対して安定であるセフロキシムアクセチルを含む医薬組成物
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
AT413647B (de) 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
AU4943000A (en) * 1999-06-11 2001-01-02 Ranbaxy Laboratories Limited Taste masked compositions
IN191239B ( ) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
CA2280925A1 (en) 1999-07-29 2001-01-29 Bernard Charles Sherman Stabilized cefuroxime axetil
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
AU2001230490A1 (en) * 2000-12-01 2002-06-11 Arun Shriniwas Gosavi Pharmaceutical formulation
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
CZ12993U1 (cs) * 2001-11-23 2003-02-10 Glaxo Group Limited Farmaceutický prostředek
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
KR100523082B1 (ko) * 2002-09-11 2005-10-20 (주)다산메디켐 쓴 맛이 은폐된 세푸록심악세틸 제제의 제약조성물 및 그의 제조방법
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
BRPI0317883B8 (pt) * 2002-12-31 2021-05-25 Boehringer Ingelheim Int comprimido revestido com filme compreendendo um extrato de folhas de vinha vermelha
US20050079213A1 (en) * 2003-06-06 2005-04-14 Unilab Pharmatech Ltd Pharmaceutical compositions
KR100552567B1 (ko) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
US20050084540A1 (en) * 2003-10-17 2005-04-21 Indranil Nandi Taste masking antibiotic composition
EP1550450A1 (en) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies
JP2007517864A (ja) * 2004-01-09 2007-07-05 ハンミ ファーム． シーオー．， エルティーディー． セフロキシムアキセチル顆粒及びこの製造方法
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
RU2367464C2 (ru) * 2004-02-19 2009-09-20 Берингер Ингельхайм Интернациональ Гмбх Состав для лечения хронических венозных недостаточностей, содержащий водный экстракт листьев красного винограда и противовоспалительное средство
ATE378042T1 (de) * 2004-04-12 2007-11-15 Pfizer Prod Inc Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
EP2091519B1 (en) * 2006-11-30 2015-06-24 Bend Research, Inc Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US8529914B2 (en) * 2010-06-28 2013-09-10 Richard C. Fuisz Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
MX355912B (es) 2012-02-22 2018-05-04 Duchesnay Inc Formulación de doxilamina y piridoxina y/o sus metabolitos o sales.
WO2013151516A1 (en) * 2012-04-04 2013-10-10 Mahmut Bilgic Film tablet formulations comprising cefuroxime axetil and clavulanic acid
WO2014174847A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
JP5651812B1 (ja) 2013-04-25 2015-01-14 杏林製薬株式会社 固形医薬組成物
US10028941B2 (en) 2013-07-22 2018-07-24 Duchesnay Inc. Composition for the management of nausea and vomiting
JP6018334B2 (ja) 2014-10-23 2016-11-02 杏林製薬株式会社 固形医薬組成物
CA3237792A1 (en) 2021-11-10 2023-05-19 Naho Watanabe Pharmaceutical composition having excellent dissolution properties
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3372015A (en) * 1963-11-15 1968-03-05 Pittsburgh Plate Glass Co Method of and apparatus for equalizing the cooling of a glass sheet supported on a bending mold
US3383236A (en) * 1964-04-17 1968-05-14 Merck & Co Inc Continuous pharmaceutical film coating process
FR1426194A (fr) * 1964-10-20 1966-01-28 Ile De France Nouvelle technique d'enrobage des comprimés
US3256111A (en) * 1964-12-04 1966-06-14 Abbott Lab Method for coating tablets
US3477864A (en) * 1965-05-07 1969-11-11 Sumitomo Chemical Co Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US3981984A (en) * 1968-04-01 1976-09-21 Colorcon Incorporated Color film coating of tablets and the like
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
JPS52151717A (en) * 1976-06-09 1977-12-16 Shionogi & Co Ltd Sugar coating on solid preparations
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4470980A (en) * 1980-03-07 1984-09-11 Interx Research Corp. Method of increasing oral absorption of β-lactam antibiotics
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8324152D0 (en) * 1983-09-09 1983-10-12 Glaxo Group Ltd Chemical process
EP0147780A3 (en) * 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
JPS60169416A (ja) * 1984-02-14 1985-09-02 Taisho Pharmaceut Co Ltd 素錠の表面処理方法
US4616008A (en) * 1984-05-02 1986-10-07 Takeda Chemical Industries, Ltd. Antibacterial solid composition for oral administration
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.

Also Published As

Publication number Publication date
IE59089B1 (en) 1994-01-12
CA1282331C (en) 1991-04-02
ES2002382A6 (es) 1988-08-01
DK175349B1 (da) 2004-09-06
NO173636B (no) 1993-10-04
GB8524001D0 (en) 1985-11-06
AU6323286A (en) 1987-04-02
US4897270A (en) 1990-01-30
SE8604114D0 (sv) 1986-09-29
GR862464B (en) 1987-02-02
NO863863D0 (no) 1986-09-29
GB2181052B (en) 1989-10-18
KR940000233B1 (ko) 1994-01-12
NO863863L (no) 1987-03-31
DK462486A (da) 1987-03-31
PH25702A (en) 1991-09-18
JPS62123118A (ja) 1987-06-04
FR2591597B1 (fr) 1989-06-02
IL80165A (en) 1991-06-10
EP0223365A2 (en) 1987-05-27
DE3677710D1 (de) 1991-04-04
CY1563A (en) 1991-05-17
GB8623340D0 (en) 1986-11-05
PT83459B (pt) 1989-05-12
SA91120189B1 (ar) 2001-10-07
CH672736A5 ( ) 1989-12-29
PT83459A (en) 1986-10-01
IT8648492A0 (it) 1986-09-29
AU594082B2 (en) 1990-03-01
NL8602466A (nl) 1987-04-16
IT1196644B (it) 1988-11-16
FR2591597A1 (fr) 1987-06-19
HK84990A (en) 1990-10-25
ATA260986A (de) 1991-01-15
JP2661662B2 (ja) 1997-10-08
NZ217720A (en) 1988-07-28
KR870002832A (ko) 1987-04-13
NO173636C (no) 1994-01-12
GB2181052A (en) 1987-04-15
EP0223365B1 (en) 1991-02-27
LU86613A1 (fr) 1988-04-05
IL80165A0 (en) 1986-12-31
BE905518A (fr) 1987-03-30
AT393081B (de) 1991-08-12
EP0223365A3 (en) 1988-06-08
IE862564L (en) 1987-03-30
DE3633292A1 (de) 1987-04-09
ZA867318B (en) 1987-05-27
DK462486D0 (da) 1986-09-29

Similar Documents

Publication Publication Date Title
SE8604114D0 (sv) Farmaceutisk komposition
CA2112679A1 (en) Dosage form for delivering drug in short-time period
CA2061520A1 (en) Delivery system for enhanced onset and increased potency
ES8304143A1 (es) "procedimiento para la preparacion de derivados de cefem".
NZ229891A (en) Pharmaceutical composition for the prevention of sexually transmitted diseases
MX4338E (es) Un procedimiento para la preparacion de una composicion farmaceutica oral que no tenga sabor amargo
ZA795530B (en) Pharmaceutical tablet for oral administration and process for its manufacture
FI823336L (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva benzamidderivat
IL101444A (en) Pharmaceutical compositions containing tetronic and thiotetronic acid derivatives and some novel compounds of this type
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
JPS57114508A (en) Pharmaceutical medicine for use of choline- action suppressive drug
ATE213416T1 (de) Arzneizubereitungen enthaltend cefuroxim axetil
AU3019389A (en) 6-oxo-4,5-dihydro-pyridazine derivatives, a process for their preparation and medicaments containing these compounds
SE9003902D0 (sv) Solid dosage forms of a drug
FR2511866B1 (fr) Formulations pharmaceutiques de pro-insuline humaine
ZA884942B (en) Flavoured film-coated tablet
NO930452L (no) Nye farmasoeytiske preparater av 5-(2-klor-1-hydroksyetyl)-4-metyltiazol
GB950162A (en) Medicines for the treatment of hepatic disorders
FR2683529B1 (fr) Composes pharmaceutiques gem-diphosphonates analogues du cis-platine.
GB1292496A (en) Dosage units of contraceptive preparations for human use
FI830245L (fi) Foerbaettringar beroerande via naesan intagbara farmaceutiska kompositioner
EP0252304A3 (en) Use of avarone and avarol and derivatives thereof for the preparation of a pharmaceutical composition for the control of aids and arc
AU492771B2 (en) Pharmaceutical composition for treatment and prevention of acute alcoholism
JO1718B1 (en) Solid dosage form of Muclant drug and its manufacturing processes
JPS5251032A (en) Medicines of disaccharide-glutathione derivatives

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8604114-2

Effective date: 19930401

Format of ref document f/p: F